Delivery Order SPE2DB24D1034-SPE2DB25FWDR3

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,907.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of REPATHA 140 MG/ML SURECLICK medication. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a major...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.59, is for the supply of REPATHA 140 MG/ML SURECLICK ML medication. The award has an ultimate completion date of June 13, 2025. The contract is not set aside and represents open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has a ceiling value of $3,137.04 and a completion date of June 16, 2025. The contract is not set aside for any particular type of business. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK medical products, with a ceiling value of $1,227.31 and a period of performance through March 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,525.23 award is for the delivery of the pharmaceutical product REPATHA 140 MG/ML SURECLICK, with a completion date of February 27, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICK, a pharmaceutical product, with a firm fixed price ceiling value of $1,354.01 and a performance period ending on June 10, 2025. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,400.11 firm-fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. The award has an ultimate completion date of May 20, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,648.91 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK medication. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,155.94 contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant...
This is a firm-fixed price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is for the pharmaceutical product REPATHA 140 MG/ML SURECLICK ML, with a ceiling value of $2,227.32 and a period of performance through June 9, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, particularly the military healthcare system, through...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWDR3
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has a ceiling value of $1,774.37 and a period of performance through June 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare system through December 2026.

Generated 9/14/25, 12:58 AM